Stay updated on Seagen Press Releases

Sign up to get notified when there's something new on the Seagen Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Seagen Press Releases page

  1. Check
    5 days ago
    Change Detected
    Summary
    Adds the Covid-19 and Vaccines categories and publishes a new press release announcing the FDA approval of the XFG-adapted COVID-19 vaccine (08.27.2026). Removes the Medicines and Prescription Medicines categories and deletes the HYMPAVZI press release dated 06.08.2026.
    Difference
    2%
    Check dated 2026-08-31T18:53:50.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Added a new press release item announcing that Pfizer and Valneva's Lyme disease vaccine candidate has its Marketing Authorization Application validated by the European Medicines Agency (08.14.2026). Removed an older entry describing Berobenatide Phase 2b efficacy and dosing (06.06.2026) from the press releases list.
    Difference
    2%
    Check dated 2026-08-17T19:40:05.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    A new Q2 results press release and August 2026 entry appear in the press releases list. An older webcast invitation and two category labels have been removed, altering the list of items and how users filter the archive.
    Difference
    1%
    Check dated 2026-08-10T11:59:05.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Two new press releases were added to the list for July 30, 2026 and July 29, 2026, highlighting LITFULO topline results in nonsegmental vitiligo and the European Commission's authorization of Pfizer and BioNTech's XFG-adapted COVID-19 vaccine; two May 2026 items were removed from the listing.
    Difference
    8%
    Check dated 2026-08-03T06:26:16.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    A new press release item regarding FDA priority review for TALZENNA Plus XTANDI is added, and the page’s categorization is updated with Medicines and Prescription Medicines. An older Research category and a past LORBRENA analysis release are removed to streamline the archive.
    Difference
    2%
    Check dated 2026-07-27T06:17:36.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    A new Medicines and Prescription Medicines section is added to the Press Releases page, featuring a press release announcing FDA approval of PADCEV plus Keytruda for muscle-invasive bladder cancer (07.10.2026). The page also removes the Research and Research and Pipeline categories and a May 28, 2026 Pfizer and Innovent Biologics collaboration item, reflecting a reorganization toward medicines-focused content.
    Difference
    2%
    Check dated 2026-07-12T17:45:08.000Z thumbnail image

Stay in the know with updates to Seagen Press Releases

Enter your email address, and we'll notify you when there's something new on the Seagen Press Releases page.